CellBion Statistics

Total Valuation

CellBion has a market cap or net worth of KRW 334.90 billion. The enterprise value is 313.78 billion.

Market Cap	334.90B
Enterprise Value	313.78B

Important Dates

The last earnings date was Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

CellBion has 12.83 million shares outstanding.

Current Share Class	12.83M
Shares Outstanding	12.83M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	36.41%
Owned by Institutions (%)	3.59%
Float	8.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	157.24
PB Ratio	13.52
P/TBV Ratio	13.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-41.53
EV / Sales	147.33
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-48.21

Financial Position

The company has a current ratio of 17.31, with a Debt / Equity ratio of 0.22.

Current Ratio	17.31
Quick Ratio	17.10
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	-0.84
Interest Coverage	-86.92

Financial Efficiency

Return on equity (ROE) is -54.63% and return on invested capital (ROIC) is -27.65%.

Return on Equity (ROE)	-54.63%
Return on Assets (ROA)	-23.70%
Return on Invested Capital (ROIC)	-27.65%
Return on Capital Employed (ROCE)	-24.86%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.10
Inventory Turnover	5.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +86.16% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+86.16%
50-Day Moving Average	18,724.60
200-Day Moving Average	20,106.00
Relative Strength Index (RSI)	81.57
Average Volume (20 Days)	417,689

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CellBion had revenue of KRW 2.13 billion and -7.55 billion in losses.

Revenue	2.13B
Gross Profit	70.73M
Operating Income	-7.92B
Pretax Income	-7.55B
Net Income	-7.55B
EBITDA	-7.26B
EBIT	-7.92B
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 26.60 billion in cash and 5.48 billion in debt, giving a net cash position of 21.12 billion or 1,645.89 per share.

Cash & Cash Equivalents	26.60B
Total Debt	5.48B
Net Cash	21.12B
Net Cash Per Share	1,645.89
Equity (Book Value)	24.78B
Book Value Per Share	n/a
Working Capital	26.02B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.88 billion and capital expenditures -626.78 million, giving a free cash flow of -6.51 billion.

Operating Cash Flow	-5.88B
Capital Expenditures	-626.78M
Free Cash Flow	-6.51B
FCF Per Share	-507.24

Full Cash Flow Statement

Margins

Gross Margin	3.32%
Operating Margin	-371.79%
Pretax Margin	-354.71%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CellBion does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.26%
FCF Yield	-1.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CellBion has an Altman Z-Score of 14.62 and a Piotroski F-Score of 3.

Altman Z-Score	14.62
Piotroski F-Score	3